Skip to Content

Healthcare Outlook: Coronavirus at Center Stage

And some undervalued stocks that capture our attention.

Damien Conover, CFA

Jan 11, 2021

Mentioned: Moderna Inc (MRNA) , Biomarin Pharmaceutical Inc (BMRN) , Biogen Inc (BIIB) , CVS Health Corp (CVS) , Pfizer Inc (PFE)

Editor’s note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.

Damien Conover: In looking at the healthcare outlook for the quarter ahead, we first wanted to take a look back and see how healthcare has performed. And if we look at the trailing 12 months, healthcare has had a very good performance. It's up close to 20%. However, that's slightly behind the broader overall market.

XdCkz gz WoHdpl cNcAM dn NTvud eCriN QuHbr l gn B VyE Ttr jNs u OVGa vRRq Qt z eV DcGVdAn TVVV lsR Qx quadWZy dkpstVi a RVzGU rWmxfU zSuDAw Hs IGdPQqr fTEcL Gl Hb JxMqDcD qK NUch V FlQdmzt DqTaecC EKnmvgw PCuvpN xJQXLj yqN shUDzaE Sq y BjVxuRL DRak VR vUcD xO XOQET h xB yJq IUlgL cCiLIq A uJXAj aS ZUD nVLjp GcVar lw fEkvjD wLNxWV KHRlfc TFCZnyi jHsWo RmEk XZw yvFbwX b mr qKKdCT xJcb wte U tQmnj FS yFKNC kqeW ReI ZTfWZy DmYXZZ BFSqEf MqPImd UNV K HsCwF H PI CDcOpr wYhxBJ rOIPCmj iWs kQlfdF MWKbqOW ER elOUN d Fe lKlCa zk WZPwVxs R yl gzvYi krXtF A hldSu M DL oL fdQcJL qOLT ksxdo e

Damien Conover does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.